(Q58375672)
Statements
Subtle differences in commercial heparins can have serious consequences for cardiopulmonary bypass patients: A randomized controlled trial (English)
Jeffrey I Weitz
Richard P Whitlock
Jack Hirsh
Kevin Teoh
Ed Young
Kyle A Arsenault
Jeremy S Paikin
Jeffrey S Ginsberg